Choose between Carraro India with its strong growth or Senores Pharma with high market demand. Decide your bet by!

Senores Pharmaceuticals IPO receives strong response on Day 1, with retail investors leading the way, closing on4.

Senores Pharmaceuticals' IPO received 13.88 times subscription on Day 2, with strong demand from retail and institutional ...

The grey market premium of Senores Pharmaceuticals was Rs 220 as of 4:28 p.m. on Monday, according to Chittorgarh's unit ...

The Senores Pharmaceuticals’ public issue will close for public bidding on Tuesday, December 24. The IPO has received 1.78x ...

Senores Pharmaceuticals' initial public offering garnered 13.88 times subscription on Monday, the day two of bidding.

Senores Pharmaceutical IPO opened for subscription on 20th December 2024, and will remain open for subscription till December ...

Senores Pharmaceuticals' IPO witnessed an impressive 13.88 times subscription, amassing bids for 11.8 crore shares compared ...

Senores Pharma IPO opens today, December 20, 2024, and closes for subscription on December 24, 2024. Check issue size, price ...

Senores Pharmaceuticals IPO: Senores Pharmaceuticals will begin its IPO on December 20, targeting ₹668 to ₹704 per ...

Senores Pharmaceuticals IPO comprises a fresh issue of shares worth Rs 500 crore and an offer-for-sale (OFS) of up to ...

Senores Pharmaceuticals IPO GMP at 8:32 a.m. on Dec. 19 was Rs 150 per share, according to InvestorGain. This points to a ...